Both in Pharmaceuticals
Bristol-Myers Squibb vs Regeneron Pharmaceuticals
Over the past year BMY returned +38.6% and REGN returned +50.1%; their daily moves had a correlation of 0.43.
BMY +38.6% REGN +50.1%Growth of $1, one year, split-adjusted
| Metric | BMY | REGN |
|---|---|---|
| Price | $63.20 | $942.32 |
| Market cap | $129.18B | $97.48B |
| Today | +2.41% | −3.19% |
| 1 month | +6.0% | +27.6% |
| 6 months | +11.7% | +30.7% |
| Year to date | +17.2% | +22.1% |
| 1 year | +37.3% | +46.7% |
| Revenue growth (YoY) | +5.7% | +36.3% |
| Gross margin | 71.3% | 88.8% |
| Net margin | 25.6% | 38.1% |
| P/E (TTM) | 13.9× | 20.2× |
| Price / sales | 2.6× | 5.8× |
| Net cash | -$32.05B | $6.59B |
| Dividend yield | 3.99% | 0.40% |
| Volatility (60d) | 27.8% | 37.7% |
| Short % of float | 2.5% | 2.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).